SynthesisFrontiers in medicine2025
Association between neutrophil to lymphocyte ratio and the mortality of patients with sepsis: an update systematic review and meta-analysis.
Synthesis in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Admission APRI and Early Mortality in ICU Patients with Sepsis: A Retrospective Cohort Study.Microorganisms · 2026Article
- Validation of SOFA-2 score in sepsis and exploration of its extension with additional immune markers.Journal of intensive medicine · 2026Article
- Tenascin-C, presepsin (SCD14-ST), and neutrophil-to-lymphocyte ratio as complementary circulating biomarkers for sepsis-associated organ dysfunction and 28-day all-cause mortality: A biomarker-enriched prognostic model.Journal of medical biochemistry · 2026Article
- Prognostic Value of 48-Hour Biomarker Reassessment Beyond Admission SOFA for 28-Day Mortality in Sepsis.Diagnostics (Basel, Switzerland) · 2026Article
- Acquisition Origin Matters: Clinical, Microbiological and Immunological Characteristics and Treatment Effects in Community- vs. Hospital-Acquired Septic Shock.Antibiotics (Basel, Switzerland) · 2026Article
- Admission-measured C-reactive Protein-to-albumin Ratio as a Predictive Marker for Hospital-acquired Infections in Patients with Spontaneous Intracerebral Hemorrhage.Current neurovascular research · 2026Article
- Comment on: "Predictive Value of Inflammatory Burden Index for Sepsis in Critically Ill Patients with Extensive Burns: A Decade-Long Cohort Study" [Letter].Journal of inflammation research · 2026Article
- Sepsis biomarkers: recent advances and future perspectives.Frontiers in immunology · 2026Review
- Back to basics in critical care: Can hematological ratios refine sepsis risk stratification?International journal of critical illness and injury scienceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To present the most up-to-date systematic review and meta-analysis assessing the relationship between the neutrophil-to-lymphocyte ratio (NLR) and mortality in individuals diagnosed with sepsis. Methods: We conducted a systematic literature retrieval via PubMed, Embase, Web of Science, and Cochrane Library until March, 2025 for studies which evaluated the link between NLR and the mortality of patients with sepsis. Odds ratios (OR) and 95% confidence intervals (CI) were used for data pooling. In addition, sensitivity analysis and subgroup analysis were performed to examine the stability of the results and potential sources of heterogeneity. All analyses were performed using Review Manager 5.4 and STATA 15.1. Results: A total of 21 studies including 23,621 patients were incorporated into the meta-analysis. The results demonstrated a significantly higher mortality (OR: 1.11; 95% CI: 1.08, 1.14; Conclusion: NLR was significantly associated with the risk of death in individuals diagnosed with sepsis. The higher the NLR, the higher the risk of death. Considering the potential publication bias and inevitable heterogeneity of this study, further large-sample, multicenter, prospective clinical studies are needed in the future to verify the exact link between NLR and the risk of death in patients with sepsis. Systematic review registration: Our systematic review has been registered in the International Prospective Register of Systematic Reviews (PROSPERO). The unique identifier is CRD420251050651, and the publicly accessible URL is https://www.crd.york.ac.uk/PROSPERO/view/CRD420251050651.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.